Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.
AmBisome, Cayston, Complera, Emtriva, Eviplera, Genvoya, Gilead, Gilead Sciences, the Gilead logo design, Harvoni, Hepsera, Letairis, Odefsey, Ranexa, Sovaldi, Stribild, Truvada, Tybost, Viread, Vitekta, Volibris and Zydelig are registered trademarks of Gilead Sciences, Inc. or one of its related companies. Atripla is a registered trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Lexiscan is a registered trademark of Astellas U.S. LLC. Tamiﬂ u is a registered trademark of Hoffmann-La Roche Inc. Macugen is a registered trademark of EyeTech, Inc.
Full U.S. prescribing information for Gilead products is available at www.gilead.com.